If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
COSAMIDE 50 bicalutamide 50mg film-coated tablet blister pack AUST R: 162829Active ingredients:
bicalutamide
Dosage form:
Tablet, film coated
Sponsor:
Alphapharm Pty Ltd
Phone:
1800274276
|
From
01 Aug 2025
to
14 Sep 2025
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Unexpected increase in consumer demand
Management action:
Alternative generic products are available.
|
APO-BICALUTAMIDE bicalutamide 50mg film-coated tablet blister pack AUST R: 194683Active ingredients:
bicalutamide
Dosage form:
Tablet, film coated
Sponsor:
Arrotex Pharmaceuticals Pty Ltd
Phone:
1800 195 055
|
From
03 Jan 2025
to
05 Jun 2025
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|
BI ELIGARD CP (Eligard 1 month 7.5mg and MPL-Bicalutamide 50mg, 28 pack) AUST R: 237653Active ingredients:
leuprorelin acetate
bicalutamide
Dosage form:
Injection, modified release
Sponsor:
Mundipharma Pty Ltd
Phone:
1800 188 009
|
Deletion from market:
14 Oct 2025
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
An alternative presentation is available.
|
BI ELIGARD CP (Eligard 3 month 22.5mg and MPL-Bicalutamide 50mg, 28 pack) AUST R: 238311Active ingredients:
leuprorelin acetate
bicalutamide
Dosage form:
Injection, modified release
Sponsor:
Mundipharma Pty Ltd
Phone:
1800 188 009
|
Deletion from market:
11 Jun 2025
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
An alternative presentation is available.
|
BI ELIGARD CP (Eligard 3 month 22.5mg and MPL-Bicalutamide 50mg, 84 pack) AUST R: 237652Active ingredients:
leuprorelin acetate
bicalutamide
Dosage form:
Injection, modified release
Sponsor:
Mundipharma Pty Ltd
Phone:
1800 188 009
|
Deletion from market:
15 Jul 2025
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
An alternative presentation is available.
|
CALUTEX bicalutamide 50 mg tablets blister pack AUST R: 135858Active ingredients:
bicalutamide
Dosage form:
Tablet, film coated
Sponsor:
Aspen Pharma Pty Ltd
Phone:
1300659646
|
Deletion from market:
01 May 2025
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|